CABIOĞLU, N. Et Al. 2021. TIM3 expression on TILs is associated with poor response to neoadjuvant chemotherapy in patients with locally advanced triple-negative breast cancer. BMC CANCER , vol.21, no.1 .

CABIOĞLU, N., ÖNDER, S., Oner, G., Karatay, H., TÜKENMEZ, M., Muslumanoglu, M., ... Igci, A.(2021). TIM3 expression on TILs is associated with poor response to neoadjuvant chemotherapy in patients with locally advanced triple-negative breast cancer. BMC CANCER , vol.21, no.1.

CABIOĞLU, Neslihan Et Al. "TIM3 expression on TILs is associated with poor response to neoadjuvant chemotherapy in patients with locally advanced triple-negative breast cancer," BMC CANCER , vol.21, no.1, 2021

CABIOĞLU, Neslihan Et Al. "TIM3 expression on TILs is associated with poor response to neoadjuvant chemotherapy in patients with locally advanced triple-negative breast cancer." BMC CANCER , vol.21, no.1, 2021

CABIOĞLU, N. Et Al. (2021) . "TIM3 expression on TILs is associated with poor response to neoadjuvant chemotherapy in patients with locally advanced triple-negative breast cancer." BMC CANCER , vol.21, no.1.

@article{article, author={Neslihan CABIOĞLU Et Al. }, title={TIM3 expression on TILs is associated with poor response to neoadjuvant chemotherapy in patients with locally advanced triple-negative breast cancer}, journal={BMC CANCER}, year=2021}